Compile Data Set for Download or QSAR
Found 716 with Last Name = 'kondo' and Initial = 't'
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083552(1,9-di{4-[5-amino(imino)methylbenzo[b]furan-2-ylca...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CCCCCCCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C37H44N8O6/c38-34(39)24-8-10-28-26(20-24)22-30(50-28)36(48)44-16-12-42(13-17-44)32(46)6-4-2-1-3-5-7-33(47)43-14-18-45(19-15-43)37(49)31-23-27-21-25(35(40)41)9-11-29(27)51-31/h8-11,20-23H,1-7,12-19H2,(H3,38,39)(H3,40,41)
Affinity DataKi:  0.0190nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083561(1-{4-[5-amino(imino)methylbenzo[b]thiophen-2-ylcar...)
Show SMILES NC(=N)c1ccc2sc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3s2)C(N)=N)cc1
Show InChI InChI=1S/C38H38N8O6S2/c39-35(40)23-1-7-29-25(17-23)19-31(53-29)37(49)45-13-9-43(10-14-45)33(47)21-51-27-3-5-28(6-4-27)52-22-34(48)44-11-15-46(16-12-44)38(50)32-20-26-18-24(36(41)42)2-8-30(26)54-32/h1-8,17-20H,9-16,21-22H2,(H3,39,40)(H3,41,42)
Affinity DataKi:  0.0280nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083556(1-{4-[5-amino(imino)methylbenzo[b]furan-2-ylcarbon...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CO[C@H]1CCC[C@H](CCC1)OCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C40H48N8O8/c41-37(42)25-7-9-31-27(19-25)21-33(55-31)39(51)47-15-11-45(12-16-47)35(49)23-53-29-3-1-4-30(6-2-5-29)54-24-36(50)46-13-17-48(18-14-46)40(52)34-22-28-20-26(38(43)44)8-10-32(28)56-34/h7-10,19-22,29-30H,1-6,11-18,23-24H2,(H3,41,42)(H3,43,44)/t29-,30+
Affinity DataKi:  0.0290nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083541(1-{4-[5-amino(imino)methyl-4,5,6,7-tetrahydrothien...)
Show SMILES NC(=N)N1CCc2sc(cc2C1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3CN(CCc3s2)C(N)=N)cc1
Show InChI InChI=1S/C36H44N10O6S2/c37-35(38)45-7-5-27-23(19-45)17-29(53-27)33(49)43-13-9-41(10-14-43)31(47)21-51-25-1-2-26(4-3-25)52-22-32(48)42-11-15-44(16-12-42)34(50)30-18-24-20-46(36(39)40)8-6-28(24)54-30/h1-4,17-18H,5-16,19-22H2,(H3,37,38)(H3,39,40)
Affinity DataKi:  0.0460nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083548(1-{4-[5-amino(imino)methylbenzo[b]furan-2-ylcarbon...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3o2)C(N)=N)cc1
Show InChI InChI=1S/C38H38N8O8/c39-35(40)23-1-7-29-25(17-23)19-31(53-29)37(49)45-13-9-43(10-14-45)33(47)21-51-27-3-5-28(6-4-27)52-22-34(48)44-11-15-46(16-12-44)38(50)32-20-26-18-24(36(41)42)2-8-30(26)54-32/h1-8,17-20H,9-16,21-22H2,(H3,39,40)(H3,41,42)
Affinity DataKi:  0.0570nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217306(CHEMBL112049)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CCCCCCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C36H42N8O6/c37-33(38)23-7-9-27-25(19-23)21-29(49-27)35(47)43-15-11-41(12-16-43)31(45)5-3-1-2-4-6-32(46)42-13-17-44(18-14-42)36(48)30-22-26-20-24(34(39)40)8-10-28(26)50-30/h7-10,19-22H,1-6,11-18H2,(H3,37,38)(H3,39,40)
Affinity DataKi:  0.120nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetSphingosine 1-phosphate receptor 5(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50250631(CHEMBL4093489)
Show SMILES CCCc1ccc(COc2ccc3C(C)=C(CN4CC(C4)C(O)=O)CCc3c2)c(OC)c1
Show InChI InChI=1S/C27H33NO4/c1-4-5-19-6-7-22(26(12-19)31-3)17-32-24-10-11-25-18(2)21(9-8-20(25)13-24)14-28-15-23(16-28)27(29)30/h6-7,10-13,23H,4-5,8-9,14-17H2,1-3H3,(H,29,30)
Affinity DataKi:  0.574nMAssay Description:Displacement of [33P]-S1P from human S1P5 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
TargetSphingosine 1-phosphate receptor 1(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50250631(CHEMBL4093489)
Show SMILES CCCc1ccc(COc2ccc3C(C)=C(CN4CC(C4)C(O)=O)CCc3c2)c(OC)c1
Show InChI InChI=1S/C27H33NO4/c1-4-5-19-6-7-22(26(12-19)31-3)17-32-24-10-11-25-18(2)21(9-8-20(25)13-24)14-28-15-23(16-28)27(29)30/h6-7,10-13,23H,4-5,8-9,14-17H2,1-3H3,(H,29,30)
Affinity DataKi:  0.626nMAssay Description:Agonist activity at human S1P5 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by E...More data for this Ligand-Target Pair
TargetSphingosine 1-phosphate receptor 1(Rattus norvegicus)
Ono Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50250631(CHEMBL4093489)
Show SMILES CCCc1ccc(COc2ccc3C(C)=C(CN4CC(C4)C(O)=O)CCc3c2)c(OC)c1
Show InChI InChI=1S/C27H33NO4/c1-4-5-19-6-7-22(26(12-19)31-3)17-32-24-10-11-25-18(2)21(9-8-20(25)13-24)14-28-15-23(16-28)27(29)30/h6-7,10-13,23H,4-5,8-9,14-17H2,1-3H3,(H,29,30)
Affinity DataKi:  0.772nMAssay Description:Displacement of [33P]-S1P from human S1P2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
TargetCorticotropin-releasing factor receptor 1(Homo sapiens (Human))
Minase Research Institute

Curated by ChEMBL
LigandPNGBDBM50087713((1-Ethyl-propyl)-[3-(4-methoxy-2-methyl-phenyl)-2,...)
Show SMILES CCC(CC)Nc1cc(C)nc2c(c(C)nn12)-c1ccc(OC)cc1C
Show InChI InChI=1S/C21H28N4O/c1-7-16(8-2)23-19-12-14(4)22-21-20(15(5)24-25(19)21)18-10-9-17(26-6)11-13(18)3/h9-12,16,23H,7-8H2,1-6H3
Affinity DataKi:  1nMAssay Description:Displacement of [125I]CRF from human corticotropin-releasing factor receptor 1 expressed in CHO-K1 cells after 2 hrs by gamma countingMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083549(1-{4-[5-amino(imino)methylbenzo[b]furan-2-ylcarbon...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccccc1OCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C38H38N8O8/c39-35(40)23-5-7-27-25(17-23)19-31(53-27)37(49)45-13-9-43(10-14-45)33(47)21-51-29-3-1-2-4-30(29)52-22-34(48)44-11-15-46(16-12-44)38(50)32-20-26-18-24(36(41)42)6-8-28(26)54-32/h1-8,17-20H,9-16,21-22H2,(H3,39,40)(H3,41,42)
Affinity DataKi:  1.10nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetSphingosine 1-phosphate receptor 4(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50250631(CHEMBL4093489)
Show SMILES CCCc1ccc(COc2ccc3C(C)=C(CN4CC(C4)C(O)=O)CCc3c2)c(OC)c1
Show InChI InChI=1S/C27H33NO4/c1-4-5-19-6-7-22(26(12-19)31-3)17-32-24-10-11-25-18(2)21(9-8-20(25)13-24)14-28-15-23(16-28)27(29)30/h6-7,10-13,23H,4-5,8-9,14-17H2,1-3H3,(H,29,30)
Affinity DataKi:  29nMAssay Description:Displacement of [33P]-S1P from human S1P4 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217313(CHEMBL110856)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCCCC2)cc1
Show InChI InChI=1S/C29H33N5O6/c30-28(31)20-4-9-24-21(16-20)17-25(40-24)29(37)34-14-12-33(13-15-34)27(36)19-39-23-7-5-22(6-8-23)38-18-26(35)32-10-2-1-3-11-32/h4-9,16-17H,1-3,10-15,18-19H2,(H3,30,31)
Affinity DataKi:  60nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217310(CHEMBL109688)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCNCC2)cc1
Show InChI InChI=1S/C28H32N6O6/c29-27(30)19-1-6-23-20(15-19)16-24(40-23)28(37)34-13-11-33(12-14-34)26(36)18-39-22-4-2-21(3-5-22)38-17-25(35)32-9-7-31-8-10-32/h1-6,15-16,31H,7-14,17-18H2,(H3,29,30)
Affinity DataKi:  67nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217308(CHEMBL424436)
Show SMILES CCOC(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3o2)C(N)=N)cc1
Show InChI InChI=1S/C26H28N4O7/c1-2-34-24(32)16-36-20-6-4-19(5-7-20)35-15-23(31)29-9-11-30(12-10-29)26(33)22-14-18-13-17(25(27)28)3-8-21(18)37-22/h3-8,13-14H,2,9-12,15-16H2,1H3,(H3,27,28)
Affinity DataKi:  210nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217305(CHEMBL323935)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C29H30N8O5/c30-25(31)17-1-3-21-19(13-17)15-23(41-21)27(38)34-5-9-36(10-6-34)29(40)37-11-7-35(8-12-37)28(39)24-16-20-14-18(26(32)33)2-4-22(20)42-24/h1-4,13-16H,5-12H2,(H3,30,31)(H3,32,33)
Affinity DataKi:  460nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217315(CHEMBL30862)
Show SMILES O=C(COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3CNCCc3s2)cc1)N1CCN(CC1)C(=O)c1cc2CNCCc2s1
Show InChI InChI=1S/C34H40N6O6S2/c41-31(37-9-13-39(14-10-37)33(43)29-17-23-19-35-7-5-27(23)47-29)21-45-25-1-2-26(4-3-25)46-22-32(42)38-11-15-40(16-12-38)34(44)30-18-24-20-36-8-6-28(24)48-30/h1-4,17-18,35-36H,5-16,19-22H2
Affinity DataKi:  970nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217312(CHEMBL324918)
Show SMILES N=C(NCc1ccccc1)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3o2)C(=N)NCc2ccccc2)cc1
Show InChI InChI=1S/C52H50N8O8/c53-49(55-31-35-7-3-1-4-8-35)37-11-17-43-39(27-37)29-45(67-43)51(63)59-23-19-57(20-24-59)47(61)33-65-41-13-15-42(16-14-41)66-34-48(62)58-21-25-60(26-22-58)52(64)46-30-40-28-38(12-18-44(40)68-46)50(54)56-32-36-9-5-2-6-10-36/h1-18,27-30H,19-26,31-34H2,(H2,53,55)(H2,54,56)
Affinity DataKi:  1.10E+3nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083563(1-{4-[5-amino(imino)methylaminobenzo[b]furan-2-ylc...)
Show SMILES NC(N)=Nc1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3o2)N=C(N)N)cc1
Show InChI InChI=1S/C38H40N10O8/c39-37(40)43-25-1-7-29-23(17-25)19-31(55-29)35(51)47-13-9-45(10-14-47)33(49)21-53-27-3-5-28(6-4-27)54-22-34(50)46-11-15-48(16-12-46)36(52)32-20-24-18-26(44-38(41)42)2-8-30(24)56-32/h1-8,17-20H,9-16,21-22H2,(H4,39,40,43)(H4,41,42,44)
Affinity DataKi:  1.10E+3nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217317(CHEMBL109903)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccccc1
Show InChI InChI=1S/C22H22N4O4/c23-21(24)15-6-7-18-16(12-15)13-19(30-18)22(28)26-10-8-25(9-11-26)20(27)14-29-17-4-2-1-3-5-17/h1-7,12-13H,8-11,14H2,(H3,23,24)
Affinity DataKi:  3.00E+3nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083562(2-(4-{2-[4-(5-Carbamimidoyl-benzofuran-2-carbonyl)...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)Nc2ccc(cc2)-c2c[nH]cn2)cc1
Show InChI InChI=1S/C33H31N7O6/c34-32(35)22-3-10-28-23(15-22)16-29(46-28)33(43)40-13-11-39(12-14-40)31(42)19-45-26-8-6-25(7-9-26)44-18-30(41)38-24-4-1-21(2-5-24)27-17-36-20-37-27/h1-10,15-17,20H,11-14,18-19H2,(H3,34,35)(H,36,37)(H,38,41)
Affinity DataKi:  5.30E+3nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetSphingosine 1-phosphate receptor 2(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50250631(CHEMBL4093489)
Show SMILES CCCc1ccc(COc2ccc3C(C)=C(CN4CC(C4)C(O)=O)CCc3c2)c(OC)c1
Show InChI InChI=1S/C27H33NO4/c1-4-5-19-6-7-22(26(12-19)31-3)17-32-24-10-11-25-18(2)21(9-8-20(25)13-24)14-28-15-23(16-28)27(29)30/h6-7,10-13,23H,4-5,8-9,14-17H2,1-3H3,(H,29,30)
Affinity DataKi: >5.45E+3nMAssay Description:Displacement of [33P]-S1P from rat S1P1 receptor after 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
TargetSphingosine 1-phosphate receptor 3(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50250631(CHEMBL4093489)
Show SMILES CCCc1ccc(COc2ccc3C(C)=C(CN4CC(C4)C(O)=O)CCc3c2)c(OC)c1
Show InChI InChI=1S/C27H33NO4/c1-4-5-19-6-7-22(26(12-19)31-3)17-32-24-10-11-25-18(2)21(9-8-20(25)13-24)14-28-15-23(16-28)27(29)30/h6-7,10-13,23H,4-5,8-9,14-17H2,1-3H3,(H,29,30)
Affinity DataKi: >5.63E+3nMAssay Description:Displacement of [33P]-S1P from human S1P3 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217309(CHEMBL111451)
Show SMILES CN(C)C(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3o2)C(=N)N(C)C)cc1
Show InChI InChI=1S/C42H46N8O8/c1-45(2)39(43)27-5-11-33-29(21-27)23-35(57-33)41(53)49-17-13-47(14-18-49)37(51)25-55-31-7-9-32(10-8-31)56-26-38(52)48-15-19-50(20-16-48)42(54)36-24-30-22-28(40(44)46(3)4)6-12-34(30)58-36/h5-12,21-24,43-44H,13-20,25-26H2,1-4H3
Affinity DataKi:  6.60E+3nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217314(CHEMBL112894)
Show SMILES NC(=N)NCCCCCCC(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)CCCCCCNC(N)=N)cc1
Show InChI InChI=1S/C34H56N10O6/c35-33(36)39-15-7-3-1-5-9-29(45)41-17-21-43(22-18-41)31(47)25-49-27-11-13-28(14-12-27)50-26-32(48)44-23-19-42(20-24-44)30(46)10-6-2-4-8-16-40-34(37)38/h11-14H,1-10,15-26H2,(H4,35,36,39)(H4,37,38,40)
Affinity DataKi:  1.30E+4nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217307(CHEMBL112900)
Show SMILES O=C(COc1ccc(OCC(=O)N2CCN(CC2)C(=O)CC(=O)N2CCNCC2)cc1)N1CCN(CC1)C(=O)CC(=O)N1CCNCC1
Show InChI InChI=1S/C32H46N8O8/c41-27(35-9-5-33-6-10-35)21-29(43)37-13-17-39(18-14-37)31(45)23-47-25-1-2-26(4-3-25)48-24-32(46)40-19-15-38(16-20-40)30(44)22-28(42)36-11-7-34-8-12-36/h1-4,33-34H,5-24H2
Affinity DataKi:  1.30E+4nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083556(1-{4-[5-amino(imino)methylbenzo[b]furan-2-ylcarbon...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CO[C@H]1CCC[C@H](CCC1)OCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C40H48N8O8/c41-37(42)25-7-9-31-27(19-25)21-33(55-31)39(51)47-15-11-45(12-16-47)35(49)23-53-29-3-1-4-30(6-2-5-29)54-24-36(50)46-13-17-48(18-14-46)40(52)34-22-28-20-26(38(43)44)8-10-32(28)56-34/h7-10,19-22,29-30H,1-6,11-18,23-24H2,(H3,41,42)(H3,43,44)/t29-,30+
Affinity DataKi:  1.50E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083561(1-{4-[5-amino(imino)methylbenzo[b]thiophen-2-ylcar...)
Show SMILES NC(=N)c1ccc2sc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3s2)C(N)=N)cc1
Show InChI InChI=1S/C38H38N8O6S2/c39-35(40)23-1-7-29-25(17-23)19-31(53-29)37(49)45-13-9-43(10-14-45)33(47)21-51-27-3-5-28(6-4-27)52-22-34(48)44-11-15-46(16-12-44)38(50)32-20-26-18-24(36(41)42)2-8-30(26)54-32/h1-8,17-20H,9-16,21-22H2,(H3,39,40)(H3,41,42)
Affinity DataKi:  2.20E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217316(CHEMBL113084)
Show SMILES NC(=N)NCCCCCC(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)CCCCCNC(N)=N)cc1
Show InChI InChI=1S/C32H52N10O6/c33-31(34)37-13-5-1-3-7-27(43)39-15-19-41(20-16-39)29(45)23-47-25-9-11-26(12-10-25)48-24-30(46)42-21-17-40(18-22-42)28(44)8-4-2-6-14-38-32(35)36/h9-12H,1-8,13-24H2,(H4,33,34,37)(H4,35,36,38)
Affinity DataKi:  2.30E+4nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083547(1,5-di(4-(5-amino(imino)methylbenzo[b]furan-2-ylca...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CCCCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C34H38N8O6/c35-31(36)21-5-7-25-23(17-21)19-27(47-25)33(45)41-13-9-39(10-14-41)29(43)3-1-2-4-30(44)40-11-15-42(16-12-40)34(46)28-20-24-18-22(32(37)38)6-8-26(24)48-28/h5-8,17-20H,1-4,9-16H2,(H3,35,36)(H3,37,38)
Affinity DataKi:  2.30E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083563(1-{4-[5-amino(imino)methylaminobenzo[b]furan-2-ylc...)
Show SMILES NC(N)=Nc1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3o2)N=C(N)N)cc1
Show InChI InChI=1S/C38H40N10O8/c39-37(40)43-25-1-7-29-23(17-25)19-31(55-29)35(51)47-13-9-45(10-14-47)33(49)21-53-27-3-5-28(6-4-27)54-22-34(50)46-11-15-48(16-12-46)36(52)32-20-24-18-26(44-38(41)42)2-8-30(24)56-32/h1-8,17-20H,9-16,21-22H2,(H4,39,40,43)(H4,41,42,44)
Affinity DataKi:  2.40E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083557(CHEMBL113531 | N-Benzyl-2-(4-{2-[4-(5-carbamimidoy...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)NCc2ccccc2)cc1
Show InChI InChI=1S/C31H31N5O6/c32-30(33)22-6-11-26-23(16-22)17-27(42-26)31(39)36-14-12-35(13-15-36)29(38)20-41-25-9-7-24(8-10-25)40-19-28(37)34-18-21-4-2-1-3-5-21/h1-11,16-17H,12-15,18-20H2,(H3,32,33)(H,34,37)
Affinity DataKi:  2.80E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083541(1-{4-[5-amino(imino)methyl-4,5,6,7-tetrahydrothien...)
Show SMILES NC(=N)N1CCc2sc(cc2C1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3CN(CCc3s2)C(N)=N)cc1
Show InChI InChI=1S/C36H44N10O6S2/c37-35(38)45-7-5-27-23(19-45)17-29(53-27)33(49)43-13-9-41(10-14-43)31(47)21-51-25-1-2-26(4-3-25)52-22-32(48)42-11-15-44(16-12-42)34(50)30-18-24-20-46(36(39)40)8-6-28(24)54-30/h1-4,17-18H,5-16,19-22H2,(H3,37,38)(H3,39,40)
Affinity DataKi:  2.90E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083542(1,5-di{4-[5-amino(imino)methylbenzo[b]furan-2-ylca...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CCCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C33H36N8O6/c34-30(35)20-4-6-24-22(16-20)18-26(46-24)32(44)40-12-8-38(9-13-40)28(42)2-1-3-29(43)39-10-14-41(15-11-39)33(45)27-19-23-17-21(31(36)37)5-7-25(23)47-27/h4-7,16-19H,1-3,8-15H2,(H3,34,35)(H3,36,37)
Affinity DataKi:  3.20E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083548(1-{4-[5-amino(imino)methylbenzo[b]furan-2-ylcarbon...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)c2cc3cc(ccc3o2)C(N)=N)cc1
Show InChI InChI=1S/C38H38N8O8/c39-35(40)23-1-7-29-25(17-23)19-31(53-29)37(49)45-13-9-43(10-14-45)33(47)21-51-27-3-5-28(6-4-27)52-22-34(48)44-11-15-46(16-12-44)38(50)32-20-26-18-24(36(41)42)2-8-30(26)54-32/h1-8,17-20H,9-16,21-22H2,(H3,39,40)(H3,41,42)
Affinity DataKi:  3.20E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083543(1,4-di{4-[5-amino(imino)methylbenzo[b]furan-2-ylca...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C32H34N8O6/c33-29(34)19-1-3-23-21(15-19)17-25(45-23)31(43)39-11-7-37(8-12-39)27(41)5-6-28(42)38-9-13-40(14-10-38)32(44)26-18-22-16-20(30(35)36)2-4-24(22)46-26/h1-4,15-18H,5-14H2,(H3,33,34)(H3,35,36)
Affinity DataKi:  5.10E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetTryptase beta-2/delta/gamma(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50217311(CHEMBL109660)
Show SMILES NC(=N)NCCCCC(=O)N1CCN(CC1)C(=O)COc1ccc(OCC(=O)N2CCN(CC2)C(=O)CCCCNC(N)=N)cc1
Show InChI InChI=1S/C30H48N10O6/c31-29(32)35-11-3-1-5-25(41)37-13-17-39(18-14-37)27(43)21-45-23-7-9-24(10-8-23)46-22-28(44)40-19-15-38(16-20-40)26(42)6-2-4-12-36-30(33)34/h7-10H,1-6,11-22H2,(H4,31,32,35)(H4,33,34,36)
Affinity DataKi:  8.00E+4nMAssay Description:Inhibition of tryptase activityMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083553(1,3-di{4-[5-amino(imino)methylbenzo[b]furan-2-ylca...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C31H32N8O6/c32-28(33)18-1-3-22-20(13-18)15-24(44-22)30(42)38-9-5-36(6-10-38)26(40)17-27(41)37-7-11-39(12-8-37)31(43)25-16-21-14-19(29(34)35)2-4-23(21)45-25/h1-4,13-16H,5-12,17H2,(H3,32,33)(H3,34,35)
Affinity DataKi:  8.20E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083545(1,7-di{4-[5-amino(imino)methylbenzo[b]furan-2-ylca...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CCCCCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C35H40N8O6/c36-32(37)22-6-8-26-24(18-22)20-28(48-26)34(46)42-14-10-40(11-15-42)30(44)4-2-1-3-5-31(45)41-12-16-43(17-13-41)35(47)29-21-25-19-23(33(38)39)7-9-27(25)49-29/h6-9,18-21H,1-5,10-17H2,(H3,36,37)(H3,38,39)
Affinity DataKi:  8.50E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083549(1-{4-[5-amino(imino)methylbenzo[b]furan-2-ylcarbon...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)COc1ccccc1OCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C38H38N8O8/c39-35(40)23-5-7-27-25(17-23)19-31(53-27)37(49)45-13-9-43(10-14-45)33(47)21-51-29-3-1-2-4-30(29)52-22-34(48)44-11-15-46(16-12-44)38(50)32-20-26-18-24(36(41)42)6-8-28(26)54-32/h1-8,17-20H,9-16,21-22H2,(H3,39,40)(H3,41,42)
Affinity DataKi:  8.80E+4nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Yoshitomi Pharmaceutical Industries Ltd

Curated by ChEMBL
LigandPNGBDBM50083552(1,9-di{4-[5-amino(imino)methylbenzo[b]furan-2-ylca...)
Show SMILES NC(=N)c1ccc2oc(cc2c1)C(=O)N1CCN(CC1)C(=O)CCCCCCCC(=O)N1CCN(CC1)C(=O)c1cc2cc(ccc2o1)C(N)=N
Show InChI InChI=1S/C37H44N8O6/c38-34(39)24-8-10-28-26(20-24)22-30(50-28)36(48)44-16-12-42(13-17-44)32(46)6-4-2-1-3-5-7-33(47)43-14-18-45(19-15-43)37(49)31-23-27-21-25(35(40)41)9-11-29(27)51-31/h8-11,20-23H,1-7,12-19H2,(H3,38,39)(H3,40,41)
Affinity DataKi:  2.30E+5nMAssay Description:Inhibition of thrombinMore data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM335414(4-(2-{(3S)-8-chloro-7-[5-chloro-2-(1H-tetrazol-1-y...)
Show SMILES OC(=O)c1cc(cs1)-c1cnc([nH]1)[C@@H]1CCc2c(Cl)c(cc(=O)n12)-c1cc(Cl)ccc1-n1cnnn1
Affinity DataIC50: 1.10nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM335416(5-(2-{(3S)-7-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]...)
Show SMILES OC(=O)c1ccc(s1)-c1[nH]c(nc1F)[C@@H]1CCc2cc(cc(=O)n12)-c1cc(Cl)ccc1-n1cnnn1
Affinity DataIC50: 1.10nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM335416(5-(2-{(3S)-7-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]...)
Show SMILES OC(=O)c1ccc(s1)-c1[nH]c(nc1F)[C@@H]1CCc2cc(cc(=O)n12)-c1cc(Cl)ccc1-n1cnnn1
Affinity DataIC50: 1.10nMAssay Description:Human Factor XIa activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6000, 50 mM HEPES-NaOH (pH7.4) wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM335414(4-(2-{(3S)-8-chloro-7-[5-chloro-2-(1H-tetrazol-1-y...)
Show SMILES OC(=O)c1cc(cs1)-c1cnc([nH]1)[C@@H]1CCc2c(Cl)c(cc(=O)n12)-c1cc(Cl)ccc1-n1cnnn1
Affinity DataIC50: 1.10nMAssay Description:Human Factor XIa activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6000, 50 mM HEPES-NaOH (pH7.4) wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM294112(US10336741, Example 99 | US10882855, Example 99 | ...)
Show SMILES COC(=O)Nc1ccc(cc1)-c1[nH]c(nc1Cl)[C@@H]1C[C@@H](CN1C(=O)C1CCN(CC1)C(N)=N)N1CCN(CC1)S(C)(=O)=O
Affinity DataIC50: 1.20nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM294112(US10336741, Example 99 | US10882855, Example 99 | ...)
Show SMILES COC(=O)Nc1ccc(cc1)-c1[nH]c(nc1Cl)[C@@H]1C[C@@H](CN1C(=O)C1CCN(CC1)C(N)=N)N1CCN(CC1)S(C)(=O)=O
Affinity DataIC50: 1.20nMAssay Description:Inhibitory activities of compounds of the present invention against factor XIa, Xa, XIIa, IXa, VIIa, plasma kallikrein or thrombin were evaluated usi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM294112(US10336741, Example 99 | US10882855, Example 99 | ...)
Show SMILES COC(=O)Nc1ccc(cc1)-c1[nH]c(nc1Cl)[C@@H]1C[C@@H](CN1C(=O)C1CCN(CC1)C(N)=N)N1CCN(CC1)S(C)(=O)=O
Affinity DataIC50: 1.20nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM238267(US9394250, 99)
Show SMILES COC(=O)Nc1ccc(cc1)-c1[nH]c(nc1Cl)[C@@H]1C[C@@H](CN1C(=O)C1CCC(CC1)C(N)=N)N1CCN(CC1)S(C)(=O)=O
Affinity DataIC50: 1.20nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetCoagulation factor XI(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd

US Patent
LigandPNGBDBM335412(4-(2-{(3S)-7-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]...)
Show SMILES OC(=O)c1cc(cs1)-c1cnc([nH]1)[C@@H]1CCc2cc(cc(=O)n12)-c1cc(Cl)ccc1-n1cnnn1
Affinity DataIC50: 1.40nMAssay Description:Human Factor XIa activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6000, 50 mM HEPES-NaOH (pH7.4) wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
Displayed 1 to 50 (of 716 total ) | Next | Last >>
Jump to: